| Health / Medical Topics |
Smoothened Antagonist LEQ506
An orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Smoothened antagonist LEQ506 selectively binds to the Hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway, thereby inhibiting tumor cell growth. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Dysregulated activation of Hh pathway signaling and uncontrolled cellular proliferation, as is observed in a variety of cancers, may be associated with mutations in the Hh-ligand cell surface receptor Smo. (NCI Thesaurus)
YOU MAY ALSO LIKE
A topical formulation of the small-molecule Smoothened (Smo) antagonist LDE225 with potential antineoplastic activity. Upon topical application, smoothened antagonist LDE225 selectively binds…
An orally bioavailable small molecule SMO (Smoothened) inhibitor with potential antineoplastic activity. SMO inhibitor BMS-833923 inhibits the sonic hedgehog (SHH) pathway protein…
Involuntary muscle tissue of the internal organs. It is composed of elongated muscle cells or fibers that are not arranged in a…
A benign or malignant myomatous neoplasm arising from smooth muscle. -- 2003
Smooth Muscle Myosin Heavy Chain 11, encoded by the human MYH11 gene belonging to the myosin heavy chain family. This protein is…
An elongated spindle-shaped contractile cell, peculiar to an involuntary muscle, containing a single nucleus and longitudinally arranged myofibrils.
